Stem cell transplantation in advanced cutaneous T-cell lymphoma
Authors:
- Brian LeberBLBrian Leber
- Kathleen GreeneKGKathleen Greene
- Ravi UbrianiRURavi Ubriani
- Alain H. RookARAlain H. Rook
- Ellen J. KimEKEllen J. Kim
- 1 April 2008
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 58 (4) , 645-649
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- High Clinical Response Rate with Multimodality Immunomodulatory Therapy for Sézary SyndromeClinical Lymphoma Myeloma and Leukemia, 2006
- WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspectsJournal of Cutaneous Pathology, 2005
- Cellular adoptive immunotherapy after allogeneic stem cell transplantationCurrent Opinion in Oncology, 2005
- High-dose therapy and bone marrow transplantation in cutaneous T-cell lymphomaHematology/Oncology Clinics of North America, 2003
- Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphomaBlood, 2003
- Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary SyndromeArchives of Dermatology, 2003
- T‐cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvementBritish Journal of Haematology, 2001
- Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first centuryTransplantation Proceedings, 2000
- Cutaneous T-Cell LymphomasArchives of Dermatology, 1979